SenesTech, Inc.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US81720R5054
USD
2.92
0.21 (7.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About SenesTech, Inc. stock-summary
stock-summary
SenesTech, Inc.
Chemicals & Petrochemicals
SenesTech, Inc. is a biotechnology company that has developed a technology for managing animal pest populations, initially rat populations, through fertility control. Its product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. Its pipeline includes feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Its Feral animal fertility control has its application in the population management segment and targets feral dogs and hogs. Its Non-Surgical Spay and Neutering have its application in companion animal health, and targets companion dogs and cats. The Company's Boar taint has its application in food production and safety and targets boars.
Company Coordinates stock-summary
Company Details
3140 N Caden Ct Ste 1 , FLAGSTAFF AZ : 86004-9428
stock-summary
Tel: 1 928 7794143
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.86%)

Foreign Institutions

Held by 2 Foreign Institutions (0.56%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Jamie Morrison
Independent Chairman of the Board
Mr. Kenneth Siegel
Chief Executive Officer, Director
Ms. Delphine Chiavarini
Independent Director
Mr. Marc Dumont
Independent Director
Mr. Phil Grandinetti
Independent Director
Ms. K. Kavanagh
Independent Director
Mr. Jake Leach
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 25 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.83

stock-summary
Return on Equity

-86.70%

stock-summary
Price to Book

3.56